New Adefovir (PMEA) prodrugs with a pro-moiety consisting of decyl or decyloxyethyl chain bearing hydroxyl function(s), hexaethyleneglycol or a (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl unit were prepared starting from the tetrabutylammonium salt of the phosphonate drug and an appropriate alkyl bromide or tosylate. Analogously, two esters of Cidofovir [(S)-HPMPC] bearing a hexaethyleneglycol moiety were prepared. The activity of the prodrugs was evaluated in vitro against different virus families. A loss in the antiviral activities of the hydroxylated decyl or decyloxyethyl esters and hexaethyleneglycol esters of PMEA against human immunodeficiency virus (HIV) and herpesviruses [including herpes simplex virus (HSV), varicella-zoster virus (VZV), and human cytomegalovirus (CMV)] occurred in comparison with the parent compound. On the other hand, the (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl ester of PMEA showed significant activities against HIV and herpesviruses. (S)-HPMPC prodrugs exhibited anti-cytomegalovirus activities in the same range as the parent drug, whereas the anti-HSV and anti-VZV activities were one- to seven-fold lower than that of Cidofovir.

Gilead Sciences and IOCB Research Centre Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Prague 166 10 Czech Republic

Zobrazit více v PubMed

De Clercq E. Antiviral Res. 2007;75:1. PubMed

Lee W.A., Martin J.S. Antiviral Res. 2006;71:254. PubMed

Zídek Z., Kmoníčková E., Holý A. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2005;149:315. PubMed

Sun C.Q., Cheng P.T.W., Stevenson J., Dejneka T., Brown B., Wang T.C., Robl J.A., Poss M.A. Tetrahedron Lett. 2002;43:1161.

Sakamoto F., Ikeda S., Tsukamoto G. Chem. Pharm. Bull. 1984;32:2241. PubMed

Saneyoshi M., Morozumi M., Kodama K., Machida H., Kuninaka A., Yoshino H. Chem. Pharm. Bull. 1980;28:2915. PubMed

Beadle J.R., Hartline C., Aldern K.A., Rodriguez N., Harden E., Kern E.R., Hostetler K.Y. Antimicrob. Agents Chemother. 2002;46:2381. PubMed PMC

Hostetler K.Y. Antiviral Res. 2009;82:A84. PubMed PMC

Serafinowska H.T., Ashton R.J., Bailey S., Harnden M.R., Jackson S.M., Sutton D. J. Med. Chem. 1995;38:1372. PubMed

Starrett J.E., Tortolani D.R., Russell J., Hitchcock M.J.M., Whiterock V., Martin J.C., Mansuri M.M. J. Med. Chem. 1994;37:1857. PubMed

Holý A. Synthesis. 1998;29:381.

Loiseau F.A., Hii K.K., Hill A.M. J. Org. Chem. 2004;69:639. PubMed

Wan W.B., Beadle J.R., Hartline C., Kern E.R., Ciesla S.L., Valiaeva N., Hostetler K.Y. Antimicrob. Agents Chemother. 2005;49:656. PubMed PMC

Valiaeva N., Beadle J.R., Aldern K.A., Trahan J., Hostetler K.Y. Antiviral Res. 2006;72:10. PubMed

Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety